In this study, we address the early detection challenges of Alzheimer’s disease (AD) using explainable artificial intelligence (XAI) techniques. AD, characterized by amyloid plaques and tau tangles, leads to cognitive decline and remains hard to diagnose due to genetic and environmental factors. Utilizing deep learning models, we analyzed brain MRI scans from the ADNI database, categorizing them into normal cognition (NC), mild cognitive impairment (MCI), and AD. The ResNet-50 architecture was employed, enhanced by a channel-wise attention mechanism to improve feature extraction. To ensure model transparency, we integrated local interpretable model-agnostic explanations (LIMEs) and gradient-weighted class activation mapping (Grad-CAM), highlighting significant image regions contributing to predictions. Our model achieved 85% accuracy, effectively distinguishing between the classes. The LIME and Grad-CAM visualizations provided insights into the model’s decision-making process, particularly emphasizing changes near the hippocampus for MCI. These XAI methods enhance the interpretability of AI-driven AD diagnosis, fostering trust and aiding clinical decision-making. Our approach demonstrates the potential of combining deep learning with XAI for reliable and transparent medical applications.

Biomarker identification is very important to differentiate the grade groups in the histopathological sections of prostate cancer (PCa). Assessing the cluster of cell nuclei is essential for pathological investigation. In this study, we present a computer-based method for cluster analyses of cell nuclei and performed traditional (i.e., unsupervised method) and modern (i.e., supervised method) artificial intelligence (AI) techniques for distinguishing the grade groups of PCa. Two datasets on PCa were collected to carry out this research. Histopathology samples were obtained from whole slides stained with hematoxylin and eosin (H&E). In this research, state-of-the-art approaches were proposed for color normalization, cell nuclei segmentation, feature selection, and classification. A traditional minimum spanning tree (MST) algorithm was employed to identify the clusters and better capture the proliferation and community structure of cell nuclei. K-medoids clustering and stacked ensemble machine learning (ML) approaches were used to perform traditional and modern AI-based classification. The binary and multiclass classification was derived to compare the model quality and results between the grades of PCa. Furthermore, a comparative analysis was carried out between traditional and modern AI techniques using different performance metrics (i.e., statistical parameters). Cluster features of the cell nuclei can be useful information for cancer grading. However, further validation of cluster analysis is required to accomplish astounding classification results.

(1) Background: Among lung diseases, idiopathic pulmonary fibrosis (IPF) appears to be the most common type and causes scarring (fibrosis) of the lungs. IPF disease patients are recommended to undergo lung transplants, or they may witness progressive and irreversible lung damage that will subsequently lead to death. In cases of irreversible damage, it becomes important to predict the patient’s mortality status. Traditional healthcare does not provide sophisticated tools for such predictions. Still, because artificial intelligence has effectively shown its capability to manage crucial healthcare situations, it is possible to predict patients’ mortality using machine learning techniques. (2) Methods: This research proposed a soft voting ensemble model applied to the top 30 best-fit clinical features to predict mortality risk for patients with idiopathic pulmonary fibrosis. Five machine learning algorithms were used for it, namely random forest (RF), support vector machine (SVM), gradient boosting machine (GBM), XGboost (XGB), and multi-layer perceptron (MLP). (3) Results: A soft voting ensemble method applied with the combined results of the classifiers showed an accuracy of 79.58%, sensitivity of 86%, F1-score of 84%, prediction error of 0.19, and responsiveness of 0.47. (4) Conclusions: Our proposed model will be helpful for physicians to make the right decision and keep track of the disease, thus reducing the mortality risk, improving the overall health condition of patients, and managing patient stratification.

International Classification of Diseases (ICD) codes enable correct billing, insurance reimbursement, and healthcare analytics. However, manual coding is time-consuming, expensive, and error-prone, creating bottlenecks in clinical workflow and limiting scalability. Artificial intelligence (AI) has emerged as a promising solution for automated ICD code assignment from unstructured clinical text. This systematic review explores the current state of automated ICD coding research, examining models applied to diverse clinical documents including discharge summaries, electronic health records, nursing notes, and pathology reports. Following PRISMA guidelines, we searched six databases for studies published between 2019 and 2024, selecting 54 relevant studies from 4,280 initial citations. Our analysis reveals the use of diverse datasets, preprocessing techniques, and feature extraction methods, alongside a clear evolution from traditional machine learning to deep learning approaches, with substantial architectural diversity across convolutional, recurrent, transformer, and hybrid models. Performance varies considerably across dataset configurations, with models achieving higher accuracy on frequent code subsets compared to full label spaces. However, critical gaps persist: overreliance on single-language, single-institution datasets limits generalizability; difficulties in predicting rare codes remain unresolved; lack of model interpretability undermines clinical trust; and inconsistent evaluation protocols hinder meaningful comparison. To address these challenges, we propose a 5P evidence-grounded research agenda: Population Diversity, Performance Robustness, Prediction of Rare Codes, Provenance Transparency, and Practical Integration. These findings underscore AI’s potential to transform ICD coding while highlighting the need for standardized benchmarks, rigorous external validation, multilingual datasets, and explainable architectures to enable equitable and effective deployment in real-world healthcare systems.

In modern times, sustainability in supply chain management is one of the keys to boosting the performance of the supply chain, and it enables the accomplishment of SSCM. It has been found in recent years that SSCM with assist of industry 4.0 applications, can benefit splendid productivity and efficiency in the supply chain. The numerous industry 4.0 applications that are involved are Artificial intelligence (AI), Machine Learning (ML), Internet of Things (IoT) Big Data Analytics (BDA), etc. Industry 4.0 with SSCM has gained a lot of interest from various authors and scholars across the world. Healthcare is one of the most critical sectors due to its importance in handling public health. More recently, the COVID-19 pandemic and other viruses (SARS and Ebola) have highlighted supply chain vulnerabilities that are further mitigated by their lean and globalized structures. Covid-19 underlined the need for supply chain visibility problems within the healthcare sector. When the need for medical supplies became urgent and global distribution was disrupted, companies faced the consequences of needing the technology, systems, and plans in place to correctly predict the onslaught. One report shows that about 94 percent of Fortune 1000 companies reported supply chain disruptions due to the COVID-19 global outbreak. Existing studies have discussed supply chain issues and the importance of AI in addressing these challenges. AI, like Industry 4.0 in the healthcare supply chain, is proving to be a game-changer. This paper aims to review and present the various aspects of SSCM and industry 4.0 applications to get a comprehensive literature review, which contains the analysis of multiple articles published from 2010-2020. In addition, the various challenges SSCM and industry 4.0 applications face are identified and discussed. Also, the impact of Industry 4.0 and sustainable practices brings together the healthcare supply chain. This study will help in getting a good understanding of the different industry 4.0 technologies that are important for setting up SSCM.